KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO
Corporate
KBI Biopharma, Inc. and Selexis SA, both JSR Life Sciences companies, announced the appointment of J.D. Mowery as Chief Executive Officer (CEO).
For details, please see the announcement from JSR Life Sciences LLC on URL.
https://news.jsrlifesciences.com/224979-kbi-biopharma-and-selexis-sa-appoint-j-d-mowery-as-ceo